OnabotulinumtoxinA in the treatment of overactive bladder: a cost-effectiveness analysis versus best supportive care in England and Wales
2015 · The European Journal of Health Economics · 14 citations
https://doi.org/10.1007/s10198-015-0737-2
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
11
Papers
47
Citations
3
h-index
3
i10-index
C. Loveman is an academic researcher from Allergan (United Kingdom). The author has contributed to research in topics: Urinary Bladder and Prostate Research & Pelvic floor disorders treatments & Anorectal Disease Treatments and Outcomes. The author has an h-index of 3, co-authored 10 publications.
https://doi.org/10.1007/s10198-015-0737-2
https://doi.org/10.1007/s40273-014-0245-8
Click to start Chat